Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
Full IRB Study Title:
Subdermal Betadine to Reduce Microbacterial Bioburden During Posterior Spinal Fusion
IRB Study ID: 2024-114
The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion. This will help us learn different ways to keep the infection rate even lower.
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Alexandria Rundell
Clinical Research Coordinator
arundell@akronchildrens.org
Who May Qualify:
Children of all ages with scoliosis who are receiving a posterior spinal fusion.
Who Does NOT Qualify:
Children who have undergone prior spinal surgery, anterior, growth-friendly instrumentation or for any patients who have any of the following, pregnancy, allergy to povidone-iodine, or prior treatment with radioiodine.
Lead Investigator
Lorena Floccari, MD
Pediatric Orthopedic Surgeon; Director, Spine Center
OrthopedicsSpine Center
